Projects per year
Search results
-
Active
HERC56: Intravital imaging as tool to bridge the gap between macroscopic in vivo imaging and microscopic tissue analysis
Hernot, S., Staels, W., Hellemans, K., Smolders, I., Rooman, I., Devoogdt, N., Menu, E., De Bundel, D., Breckpot, K., De Leu, N., Movahedi, K., D'Huyvetter, M. & De Kock, J.
1/05/22 → 30/04/26
Project: Fundamental
-
OZR3913: Cofinancing OZR FWO Hercules MZW - High-parametric single-cell protein profiling in intact tissues
Movahedi, K., van Grunsven, L., Rooman, I., Van Ginderachter, J., Smolders, I., Neyns, B., Vanhaecke, T., Laoui, D., Breckpot, K., De Veirman, K., Stijlemans, B., Van Schependom, J., Magez, S., Goyvaerts, C., De Kock, J., De Leu, N., Massie, A., Hellemans, K., Spits, C., De Bundel, D., De Trez, C., Hernot, S., Van Dooren, S., Aerts, J., Staels, W. & Tuyaerts, S.
25/02/22 → 25/02/26
Project: Fundamental
-
ANI304: TITAN: imaging and manipulation of Tumor-Infiltrating T-Cells using Anti-CD3 Nanobodies
1/11/21 → 31/10/22
Project: Fundamental
-
FWOAL1019: High intensity focused ultrasound and mRNA nanomedicines: a new strategy to induce and boost anti-tumor immunity
1/01/21 → 31/12/24
Project: Fundamental
-
IOFPOC42: IOF PoC “MOTIF: MOdification of T cells In situ for altered Functionality”
Devoogdt, N., Breckpot, K., Meeus, F., De Groof, T. & De Vlaeminck, Y.
1/01/21 → 31/12/22
Project: Applied
-
FWOSB101: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.
1/11/20 → 31/10/22
Project: Fundamental
-
OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0
Rooman, I., Bouwens, L., Heimberg, H., Neyns, B., Vranken, W., Vanhaecke, T., Massie, A., van Grunsven, L., De Bruyne, E., De Bundel, D., Forsyth, R., Breckpot, K., Van Dooren, S., De Kock, J., Njemini, R. & Laoui, D.
1/05/20 → 30/04/24
Project: Fundamental
-
-
ANI216: Prioritization of neoantigens by the combination of in silico search and mass spectrometry.
1/01/19 → 31/12/22
Project: Fundamental
-
FWOAL934: Smart design nanoParticles to Activate immune Responses against Cancer (SPARC)
Breckpot, K., Keyaerts, M., Barbé, K. & De Smedt, S.
1/01/19 → 31/12/22
Project: Fundamental
-
-
FWOSB58: Development of a NanoCAR-T cell approach for the treatment of multiple myeloma
Hanssens, H., Devoogdt, N., De Veirman, K. & Breckpot, K.
1/01/19 → 31/12/22
Project: Fundamental
-
FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.
Breckpot, K., De Beck, L. & Maes, K.
1/10/18 → 30/09/22
Project: Fundamental
-
SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)
Thielemans, K., Vanderkerken, K. & Breckpot, K.
1/11/17 → 31/10/22
Project: Fundamental
-
EU529: Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)
1/01/17 → 30/06/22
Project: Fundamental
-
OZR2835: Onderzoeksgroep Alliantie VUB - UGent - Research Consortium on particle based immunotherapy
Breckpot, K. & De Smedt, S.
10/07/15 → 10/07/24
Project: Policy Based